NY S 621
in committeeRelates to the use of topical pharmaceutical agents
New York · 2025-2026 Regular Session · upper
Quick answers
Did NY S 621 pass?
Not yet. NY S 621 is in committee as of 2026-01-07 and has not come to a final vote. Latest recorded action (2026-01-07): REFERRED TO HIGHER EDUCATION
What is NY S 621 about?
Amends the definitions of diagnostic pharmaceuticals, topical therapeutic pharmaceutical agents, and therapeutic pharmaceutical agents for treatment of glaucoma and ocular hypertension as they relate to the certification to use therapeutic drugs in the practice of optometry.
Who sponsors NY S 621?
John Liu is the primary sponsor of NY S 621, joined by 4 cosponsors.
Description
Amends the definitions of diagnostic pharmaceuticals, topical therapeutic pharmaceutical agents, and therapeutic pharmaceutical agents for treatment of glaucoma and ocular hypertension as they relate to the certification to use therapeutic drugs in the practice of optometry.
- Introduced
- —
- Latest action
- 2026-01-07 — REFERRED TO HIGHER EDUCATION
- Bill type
- bill
- Last updated
- —
Sponsors
- John Liuprimary
- Joseph P. Addabbo Jr.cosponsor
- Peter Oberackercosponsor
- Robert Rolisoncosponsor
- Jessica Scarcella-Spantoncosponsor
Committees
Not provided by source.
Action timeline
2025-01-08
REFERRED TO HIGHER EDUCATION
referral-committee
2026-01-07
REFERRED TO HIGHER EDUCATION
referral-committee
Versions
- S621Compare
Documents
Votes
Not provided by source.
Related bills
- Prior session: S 9726not in this corpus
- Companion bill: A 2202
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=S 621. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.